- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/11 - DNA or RNA fragmentsModified forms thereof
Patent holdings for IPC class C12N 15/11
Total number of patents in this class: 18392
10-year publication summary
627
|
677
|
958
|
1035
|
1126
|
1210
|
1397
|
1450
|
1666
|
1325
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20108 |
516 |
Massachusetts Institute of Technology | 10115 |
319 |
The Broad Institute, Inc. | 1842 |
295 |
President and Fellows of Harvard College | 6002 |
273 |
Alnylam Pharmaceuticals, Inc. | 1143 |
194 |
Ionis Pharmaceuticals, Inc. | 888 |
189 |
University of Massachusetts | 2232 |
168 |
The Board of Trustees of the Leland Stanford Junior University | 6476 |
159 |
The General Hospital Corporation | 4770 |
153 |
Duke University | 3090 |
119 |
The Trustees of the University of Pennsylvania | 4349 |
114 |
CRISPR Therapeutics AG | 369 |
96 |
The Johns Hopkins University | 5714 |
94 |
University of Vienna | 112 |
88 |
Monsanto Technology LLC | 8290 |
84 |
Pioneer Hi-Bred International, Inc. | 6638 |
84 |
City of Hope | 997 |
84 |
Modernatx, Inc. | 1283 |
84 |
Flagship Pioneering Innovations VI, LLC. | 484 |
84 |
Board of Regents, The University of Texas System | 5869 |
82 |
Other owners | 15113 |